N
Nura Bio
Biotech & Life Sciences · San Francisco, United States · Founded 2018
Nura Bio™ | Developing neurotherapeutics to halt serious diseases before they progress too far MoreLess
Nura Bio is a pioneering company in the field of neuroprotective therapies, focusing on halting the progression of neurological diseases. The company targets fundamental pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity. Nura Bio serves patients affected by serious neurological conditions, offering renewed hope through innovative treatments. Operating in the biopharmaceutical market, Nura Bio's business model revolves around transforming recent scientific breakthroughs into effective neuroprotective medicines. Revenue is generated through the development and commercialization of these therapies. The company is led by a team of leading biologists, chemists, and drug developers, all united by a shared passion for revolutionizing the treatment of neurological diseases.
Keywords: neuroprotective, axon degeneration, neuroimmune regulation, neurological diseases, biopharmaceutical, innovative treatments, neuronal integrity, scientific breakthroughs, commercialization, drug development.
Company overview
Nura Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- San Francisco, United States
- Employees
- 33
- Open positions
- 3
- Dealroom signal
- 50.7
Valuation & funding
Nura Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jun 2026 | $74M | $295M | Undisclosed | ↗ |
| SERIES AOther financing | Sep 2024 | $68M | $272M | Sanofi Ventures · Euclidean Capital · Samsara BioCapital · The Column Group | ↗ |
| SERIES AOther financing | Jul 2020 | $73M | $292M | The Column Group · Euclidean Capital · Samsara BioCapital | — |
| SPINOUTOther financing | Jan 2018 | $0 | — | Oregon Health & Science University · The University of Texas Southwestern Medical School | — |
Growth signals
Nura Bio website traffic
Latest recorded traffic for Nura Bio is 4K monthly website visits, up 66.7% over the last three months. Nura Bio's team grew 10% over the past year.
Hiring
Open positions at Nura Bio
Current openings linked to this company in Dealroom.
Comparisons
Nura Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Nura Bio's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Nura Bio's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Nura Bio has talent and traffic
team presence
In the news
Latest news about Nura Bio
Recent press, funding announcements, and product moves mentioning Nura Bio — open to read from the original sources.
Market sentiment
What the market is saying about Nura Bio
An AI-synthesized read of the highest-engagement posts about Nura Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nura Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.